Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Common origin and somatic mutation patterns of composite lymphomas and leukemiasIn: Leukemia, Jg. 39, 2025, Nr. 8, S. 1960 – 1971DOI (Open Access)
-
Choroidal Manifestation of Smoldering Myeloma : Case ReportIn: Klinische Monatsblätter für Augenheilkunde, Jg. 240, 2023, Nr. 07, S. 887 – 890
-
Long-Term Follow-Up of Patients with Conjunctival Lymphoma after Individualized Lens-Sparing Electron Radiotherapy : Results from a Longitudinal StudyIn: Cancers, Jg. 15, 2023, Nr. 22, 5433DOI (Open Access)
-
MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy : imaging remission criteria and volumetric regression kineticsIn: Scientific Reports, Jg. 13, 2023, Nr. 1, 4792DOI, Online Volltext (Open Access)
-
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphomaIn: Annals of Hematology, Jg. 102, 2023, Nr. 12, S. 3445 – 3455DOI (Open Access)
-
Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarkerIn: Clinical Epigenetics, Jg. 15, 2023, Nr. 1, 3DOI (Open Access)
-
Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarkerIn: Clinical Epigenetics, Jg. 14, 2022, Nr. 1, 148DOI, Online Volltext (Open Access)
-
Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy : Results from a longitudinal studyIn: Hematological Oncology, Jg. 40, 2022, Nr. 5, S. 922 – 929DOI (Open Access)
-
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple MyelomaIn: Cancers, Jg. 14, 2022, Nr. 8, 1955DOI, Online Volltext (Open Access)
-
T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic levelIn: Genes, Chromosomes and Cancer, Jg. 61, 2022, Nr. 7, S. 432 – 436DOI, Online Volltext (Open Access)
-
The Biology of Ocular Adnexal Marginal Zone LymphomasIn: Cancers, Jg. 14, 2022, Nr. 5, 1264DOI, Online Volltext (Open Access)
-
Human cord blood b cells differ from the adult counterpart by conserved ig repertoires and accelerated response dynamicsIn: The Journal of Immunology (JI), Jg. 206, 2021, Nr. 12, S. 2839 – 2851
-
Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infectionsIn: Blood Advances, Jg. 5, 2021, Nr. 5, S. 1259 – 1272DOI (Open Access)
-
Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemiaIn: Therapeutic Advances in Hematology, Jg. 11, 2020, 2040620720933761DOI, Online Volltext (Open Access)
-
Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the malt subtype by whole genome, whole exome and targeted sequencingIn: Cancers, Jg. 12, 2020, Nr. 4, 986DOI, Online Volltext (Open Access)
-
Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemiaIn: European Journal of Haematology, Jg. 105, 2020, Nr. 6, S. 786 – 796DOI (Open Access)
-
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemiaIn: Genes, Chromosomes and Cancer, Jg. 59, 2020, Nr. 4, S. 261 – 267DOI (Open Access)
-
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLLIn: Cancers, Jg. 11, 2019, Nr. 12, S. 1833DOI (Open Access)
-
Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individualsIn: Blood, Jg. 131, 2018, Nr. 5, S. 546 – 557DOI (Open Access)
-
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemiaIn: Blood Cancer Journal, Jg. 8, 2018, Nr. 1, 11DOI, Online Volltext (Open Access)
-
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemiaIn: British Journal of Haematology, Jg. 173, 2016, Nr. 2, S. 265 – 273
-
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemiaIn: International Journal of Cancer, Jg. 138, 2016, Nr. 1, S. 121 – 124DOI (Open Access)
-
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomasIn: OncoTarget, Jg. 7, 2016, Nr. 38, S. 62627 – 62639DOI (Open Access)
-
Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive LymphomasIn: Blood, Jg. 126, 2015, Nr. 23
-
B Cells in Chronically Hepatitis C Virus-Infected Individuals Lack a Virus-Induced Mutation Signature in the TP53, CTNNB1, and BCL6 GenesIn: Journal of Virology, Jg. 87, 2013, Nr. 5, S. 2956 – 2962
-
Next generation transcriptome sequencing confirms the presence of somatic STAT3 mutations and identifies novel TNFAIP3 mutations in T Large Granular Lymphocytic Leukemia (T-LGL)In: Onkologie, Jg. 36, 2013, Nr. Suppl. 7, S. 196
-
Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic LeukemiaIn: PLoS ONE, Jg. 23, 2013, Nr. 8, S. e72107DOI (Open Access)
-
Chronic lymphocytic leukemia gone osteolytic : a case reportIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 217 – 218
-
Combined SNP Microarray Based Genomic Mapping and Next Generation Transcriptome Sequencing Confirms the Presence of Somatic STAT3 Mutations and Identifies Novel Chromosomal Imbalances and Candidate Genes in T Large Granular Lymphocytic Leukemia (T-LGL)In: Blood, Jg. 120, 2012, Nr. 21, S. 3512
-
Serum immunoglobulin alterations in patients with chronic hepatitis CIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 142 – 143
-
705 Increased prevalence of monoclonal b lymphocytosis in patients with chronic Hepatitis CIn: Journal of Hepatology, Jg. 52, 2010, Nr. Suppl. 1, S. S274
-
Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemiaIn: Leukemia Research, Jg. 34, 2010, Nr. 7, S. 892 – 898
-
Linsenschonende Elektronenbestrahlung bei konjunktivalen Non-Hodgkin Lymphomen : Monozentrische Langzeitdaten zur Efektivität und NebenwirkungenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S106DOI (Open Access)
-
Long-term Follow-Up in Patients with Stage IAE Orbital Lymphoma and Radiotherapy with Photons : Monocentric ResultsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 58 – S59
-
Molecular Mechanisms in the Pathogenesis of Composite Lymphomas
4th International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymphoma, ISCAYAHL 2020, 13 - 16 May 2020, Berlin, Germany,In: Klinische Pädiatrie. Stuttgart: Thieme, Jg. 232, 2020, Nr. 02, S. 80 -
The CLL-RT1 trial : A multi-center phase-2 trial to evaluate the efficacy and safety of zanubrutinib, a BTK inhibitor, plus tislelizumab, a PD-1 inhibitor, for treatment of patients with Richter Transformation
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 73DOI (Open Access) -
Gain of STAT3/5 locus is a recurrent cryptic aberration in T-cell prolymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 318DOI (Open Access) -
The DNA-methylation status of BCL11B in T-Cell-Large Granular Lymphocytic Leukemia - a diagnostic target
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 317DOI (Open Access) -
CDK9 Inhibition with LDC526 Is an Effective Treatment for T-Cell Prolymphocytic Leukemia (T-PLL) in VitroIn: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 130, 2017, Nr. Suppl. 1, S. 1262
-
Epigenetic analyses of T-cell large granular lymphocytic leukemia identify differentially methylated enhancer regions leading to deregulation of gene interactionsIn: Oncology Research and Treatment. Basel: Karger, Jg. 40, 2017, Nr. Suppl. 3, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 109 – 110
-
Genomic profiling of T-cell Prolymphocytic Leukemia (T-PLL) identifies novel recurrent mutations in SAMHD1 and PTPRC
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Leipzig, 14.–18. Oktober 2016,In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 3, S. 238 – 238 -
Percentage of smudge cells on routine blood smears predict time to first treatment and overall survival in patients with Binet stage A chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 139 -
Polyclonal B-Cell activation and Expansion of Monoclonal B Cells in the Peripheral Blood of Patients with Chronic Hepatitis CIn: Hepatology. Hoboken: Wiley & Sons, Jg. 52, 2010, Nr. Suppl. 1, S. 740A
-
Prevalence of B cell lymphoproliferative disorders in patients with chronic hepatitis C (CHC)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010, pp 109–206,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 157 -
Molekulare Mechanismen und deregulierte Signawege in der Entstehung seltener hämatologischer NeoplasienDuisburg ; Essen, 2020
-
Real World Patient Diagnostic and Treatment Patterns in Marginal Zone Lymphoma (MZL) : First Results of the Prospective National MZL Registry of the German Lymphoma Alliance
66th ASH Annual Meeting, December 7-10, 2024, San Diego, CA, USA,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 4394 – 4395DOI (Open Access) -
Anti-leukemic activity through CDK9 inhibition in T-cell prolymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 218DOI (Open Access)